BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34665155)

  • 1. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis.
    Ramsey ML; Gokun Y; Sobotka LA; Wellner MR; Porter K; Kirkby SE; Li SS; Papachristou GI; Krishna SG; Stanich PP; Hart PA; Conwell DL; Lara LF
    Am J Gastroenterol; 2021 Dec; 116(12):2446-2454. PubMed ID: 34665155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis.
    Akshintala VS; Kamal A; Faghih M; Cutting GR; Cebotaru L; West NE; Jennings MT; Dezube R; Whitcomb DC; Lechtzin N; Merlo CA; Singh VK
    Pancreatology; 2019 Dec; 19(8):1023-1026. PubMed ID: 31611131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFTR and/or pancreatitis susceptibility genes mutations as risk factors of pancreatitis in cystic fibrosis patients?
    Gaitch N; Hubert D; Gameiro C; Burgel PR; Houriez F; Martinez B; Honoré I; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
    Pancreatology; 2016; 16(4):515-22. PubMed ID: 27086061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review.
    Ramsey ML; Li SS; Lara LF; Gokun Y; Akshintala VS; Conwell DL; Heintz J; Kirkby SE; McCoy KS; Papachristou GI; Patel A; Singh VK; Hart PA
    J Cyst Fibros; 2023 Mar; 22(2):193-200. PubMed ID: 36008229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders.
    Baldwin C; Zerofsky M; Sathe M; Troendle DM; Perito ER
    Pancreas; 2019 Aug; 48(7):888-893. PubMed ID: 31268981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Promising Way to Change the Impact of Cystic Fibrosis.
    Gómez-Montes E; Salcedo Lobato E; Galindo Izquierdo A; García Alcázar D; Villalain González C; Moral-Pumarega MT; Bustos Lozano G; Luna-Paredes C
    Fetal Diagn Ther; 2023; 50(2):136-142. PubMed ID: 36996799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CFTR modulators on pharmacokinetics of tobramycin during acute pulmonary exacerbations in the pediatric cystic fibrosis population.
    Albright JC; Houck AP; Pettit RS
    Pediatr Pulmonol; 2020 Oct; 55(10):2662-2666. PubMed ID: 32568427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report.
    Johns JD; Rowe SM
    BMC Gastroenterol; 2019 Jul; 19(1):123. PubMed ID: 31296159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
    Ooi CY; Durie PR
    J Cyst Fibros; 2012 Sep; 11(5):355-62. PubMed ID: 22658665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis.
    Burgener EB; Moss RB
    Curr Opin Pediatr; 2018 Jun; 30(3):372-377. PubMed ID: 29538046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis.
    Gould MJ; Smith H; Rayment JH; Machida H; Gonska T; Galante GJ
    J Cyst Fibros; 2022 Jul; 21(4):600-602. PubMed ID: 34732308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis.
    Stephenson KG; Lingle AJ; Baumberger KA; Dellon EP; Esther CR; Meier EM; Oermann CM; Shenoy VK; Smith NR; Wimmer NS; Duehlmeyer SR; Kam CW; McKinzie CJ; Poisson MO; Elson EC
    J Cyst Fibros; 2023 Nov; 22(6):996-1001. PubMed ID: 37758535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic pancreatitis in patients with cystic fibrosis.
    Gooding I; Bradley E; Puleston J; Gyi KM; Hodson M; Westaby D
    Am J Gastroenterol; 2009 Jun; 104(6):1519-23. PubMed ID: 19491865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A foetus with cystic fibrosis - To treat or not to treat?
    Padmakumar N; Khan HS
    Respir Med Res; 2023 Jun; 83():101006. PubMed ID: 37037055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.
    Lee SE; Farzal Z; Daniels MLA; Thorp BD; Zanation AM; Senior BA; Ebert CS; Kimple AJ
    Am J Rhinol Allergy; 2020 Jul; 34(4):573-580. PubMed ID: 32168995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.
    Bishop MD; Freedman SD; Zielenski J; Ahmed N; Dupuis A; Martin S; Ellis L; Shea J; Hopper I; Corey M; Kortan P; Haber G; Ross C; Tzountzouris J; Steele L; Ray PN; Tsui LC; Durie PR
    Hum Genet; 2005 Dec; 118(3-4):372-81. PubMed ID: 16193325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis.
    Westhölter D; Beckert H; Straßburg S; Welsner M; Sutharsan S; Taube C; Reuter S
    J Cyst Fibros; 2021 Nov; 20(6):1072-1079. PubMed ID: 34030985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of acinar apoptosis occurs during acute pancreatitis in the human homologue DeltaF508 cystic fibrosis mouse.
    DiMagno MJ; Lee SH; Owyang C; Zhou SY
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G400-12. PubMed ID: 20522641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function.
    Zhang S; Shrestha CL; Kopp BT
    Sci Rep; 2018 Nov; 8(1):17066. PubMed ID: 30459435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.